Alira Health Published in Business Development & Licensing Journal
Understanding the Value of Market Access Insights for Licensing Deals
Experts from the Alira Health team recently shared their thoughts regarding the importance of market access insights for the success of licensing operations with professionals from the Pharmaceutical Licensing Group and the International Pharma Licensing Symposium.
The article, “Understanding the Value of Market Access Insights for Licensing Deals” discusses the continuum of services / personalized multi-practice” model developed by Alira Health and the value it brings to its clients.
Pharmaceutical Licensing Group members can also read the full September 2021 publication here.
Reimbursement of Rare Disease Drugs in Italy: Challenges and Hopes for the Future
When it comes to rare diseases, Italy has done a good job in bringing EMA-approved drugs, including orphan drugs, to the Italian market. But multiple challenges exist, many of which(...)
Pharmaceutical Market Access in the UK: A Changing Landscape
Start reading this interview with Rachel Fyson to gain insight into the changing landscape of market access in the United Kingdom.
Lifecycle Optimization: The Path to Commercial Success
Pharmaceutical and biotech companies constantly focus on product innovation. But how can you also increase your effectiveness in order to be as commercially competitive and efficient as possible?
Alira Health Joins EMIG to Advance Market Access in the UK
We are pleased to announce that Alira Health has joined the Ethical Medicines Industry Group (EMIG), a multi-stakeholder network and trade association that represents the interests(...)
The State of Market Access in Italy 2023
To learn about the state of market access in Italy today, we spoke with Giovanni Firenze, Director of Market Access Italy for Alira Health, who attended the recent 2023 Conferenza Nazionale(...)
World EPA Congress 2023
We are pleased to share that we will be participating in World EPA Congress 2023 as speakers and sponsors. World Evidence, Pricing and Access Congress is Europe’s largest congress(...)
Market Access in Catalonia: 2022 Trends and What’s Next
Alira Health contributed to the recently published 2022 BioRegion Report, the most extensive analysis of the assets, achievements, and trends in the life sciences and healthcare sector(...)
Subscribe to our newsletter for the latest news, events, and thought leadership